@Click_Tx profile picture
Click Therapeutics™ @Click_Tx

Expanding the possibilities of medicine with patient-centric digital treatments. #clicktherapeutics #digitaltherapeutics #softwareenhanceddrugs

Joined July 2012
  • Tweets 328
  • Following 11
  • Followers 762
188 Photos and videos
Smartphones are becoming treatment devices. From chronic pain to mental health, Software-Enhanced Drug™ Therapies are reshaping care. Our CEO, David Klein, joined @Medidata's “from Dreamers to Disruptors” to share how Click is advancing this future: medidata.com/en/from-dreamer…

from Dreamers to Disruptors | Medidata Solutions

This is a call to the world’s visionaries who made waves. The ones who gave themselves the green light to turn bold dreams into disruptive realities and shake up the status quo. Hear straight from...

medidata.com
Medidata
@Medidata
16 Sep 2025
Is software becoming the new medicine? 📱💊 🎙️ Find out now in a new episode of "from Dreamers to Disruptors": mdso.io/j9v
0:37
1
2
608
Our abstract “Combining Digital Therapeutics with Neuroplasticity-Inducing Agents: A Framework Modeled on MAT” was accepted for #ISCTM 2025! This framework pairs PDTs with neuroplasticity-inducing agents to standardize care. Learn more on @ISCTM: isctm.org/
1
3
227
The next breakthroughs in migraine care won’t be pills. In @MedCityNews, Click CMO Shaheen Lakhan discusses how digital tools like Click's CT-132 – a PTD for the preventive treatment of episodic migraine – are transforming treatment. Read more: medcitynews.com/2025/08/the-…

The Next Big Breakthroughs in Migraine Won’t Be Pills - MedCity News

In the current phase of evolution, next-generation digital services and treatments that allow better understanding of migraine triggers, the freedom of on-demand preventative action, and pain relief...

medcitynews.com
1
1
152
In partnership with @Boehringer Ingelheim, Click Therapeutics is proud to share that CT-155 has met the primary endpoint in the CONVOKE Study, marking a positive step forward for patients suffering from negative symptoms of schizophrenia. Learn more: clicktherapeutics.com/news/b…

Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets...

Click Therapeutics is redefining modern medicine with patient-centric digital treatments. Operating at the intersection of biology and technology, Click combines neuroscience with the power of...

clicktherapeutics.com
2
3
204
ICYMI: Click Therapeutics leadership sat down with @Medidata on July 24 for an in-depth discussion on what the next frontier of patient care looks like. One key takeaway: Personalization through digitization is key. Missed the conversation? Watch here: medidata.com/en/click-webina…
1
2
286
We’re heading to #BIO2025! Join Click at Booth 3678 where our team will be on-site and available for meetings to explore strategic partnerships across PDTs and Software-Enhanced Drug™ therapies. Looking to connect? Contact bd@clicktherapeutics.com
1
224
Click will be at #ASCO25, where our CMO Shaheen Lakhan, MD, PhD, FAAN will present our innovative oncology research. Visit us at Booth #13093, and reach out to bd@clicktherapeutics.com to request a meeting. Learn more: meetings.asco.org/meetings/2… @ASCO
1
201
CT-132, Click’s prescription digital therapeutic for migraine prevention, was featured in @neurology_live with insights from Eric Baron, DO of Cleveland Clinic. He shares how this FDA-authorized, app-based treatment can complement existing therapies: neurologylive.com/view/eric-…

Eric Baron, DO, on the Approval of CT-132: A Digital Shift in Migraine Care | NeurologyLive -...

Baron, a neurologist and headache specialist at Cleveland Clinic, explained the significance, clinical data, and patient potential behind CT-132, the first FDA-approved digital therapeutic for...

neurologylive.com
1
1
277
Is tech friend or foe to our brains? It depends how we use it. In @Medscape, our CMO Shaheen Lakhan shares insights on how digital tools can erode or nourish cognitive health. At Click, we build treatments that turn tech into a tool for good. Read more: medscape.com/viewarticle/dig…
1
114
We’re proud to share that our Founder and CEO, David Klein, is a finalist for @EY_US Entrepreneur Of The Year New York! This honor recognizes David’s commitment to innovation and his impact on the future of patient care. Congrats to all the finalists! ey.com/en_us/entrepreneur-of…
109
Click will present Phase 3 data from the ReMMiD-C bridging study of CT-132 at the @ahsheadache 2025 Annual Scientific Meeting on Saturday, June 21 at 9:10 AM CST. Cassandra Snipes, PhD, will present abstract IOR-05. Learn more: ahsam25.eventscribe.net/fsPo… #AHSAM
106
CT-132, the first prescription digital therapeutic for the preventive treatment of episodic migraine in patients 18 years of age and older, has received FDA marketing authorization. Learn more: clicktherapeutics.com/news/c…
3
101
Click was honored to present a poster at the AAN annual meeting on the effectiveness and safety of our first-in-class investigational PDT for the preventive treatment of episodic migraine. Read more at: medscape.com/viewarticle/fir… #AANAM #AAN2025
1
145
Click Therapeutics Founder & CEO, David Benshoof Klein, delivered a keynote address at Medidata NEXT in London last week, where Click announced closing its Series C investment round, provided entirely by @Dassault3DS . Read more here: clicktherapeutics.com/news/c…
1
1
258
Click Therapeutics™ retweeted
Medidata
@Medidata
19 Mar 2025
BREAKING NEWS: @Dassault3DS and Medidata have made a strategic investment in @Click_Tx. 25 years ago we revolutionized clinical trials. Today, we’re expanding the boundaries of healthcare by combining cutting-edge science with the power of software to develop new, cutting-edge patient solutions. Learn more: mdso.io/zck
2
4
292
Today, @Dassault3DS @Medidata announced a strategic investment in Click, having provided the entire Series C funding round. The collaboration will provide a clear path to best-in-class PDTs and Software-Enhanced Drugs™ product approvals. Learn more: medidata.com/en/about-us/new…
1
2
189
Click Therapeutics Founder and Chief Executive Officer David Benshoof Klein shared his predictions for the pharma industry in 2025 in Healthcare IT Today. To learn more on David's insights for the new year, read the full article at: healthcareittoday.com/2025/0…

Pharma - 2025 Health IT Predictions

As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone's favorite annual tradition of Health IT Predictions! We reached

healthcareittoday.com
2
184
In his latest article for @medcitynews , our CMO Shaheen Lakhan explores how smartphones and social media contribute to a growing mental health crisis - and how the same technology that poses risks can also offer transformative health benefits. Learn more: medcitynews.com/2024/12/the-…

The Same Processes that Make Smartphones a Risk for Young People Must Be Harnessed to Provide...

Addressing difficult-to-treat diseases and disorders, quickly, safely, and with little to no side effects is a positive boon to our overburdened health system.

medcitynews.com
2
390
Click is headed to Berlin for the @FrontiersHealth Congress taking place October 17-18. Our CEO & Founder, David Benshoof Klein, will take the stage to share his insights on the future of medicine in a keynote and fireside chat. Learn more: frontiers.health/2024-agenda
1
2
342
Click is honored to share that our CEO David Benshoof Klein has been named to the 2024 @PharmaVoice 100 list, recognizing him as a top leader in the life-sciences industry within Tech and AI. Check out the full list of inspiring leaders: pharmavoice.com/news/pv100-p… #PharmaVoice100
1
244
Load more